Marker Therapeutics, Inc.MRKRNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank64
3Y CAGR-7.0%
5Y CAGR-2.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-7.0%/yr
vs -47.4%/yr prior
5Y CAGR
-2.7%/yr
Recent deceleration
Acceleration
+40.4pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $9.12M | +115.1% |
| 2024 | $4.24M | -43.3% |
| 2023 | $7.48M | -34.1% |
| 2022 | $11.34M | -69.8% |
| 2021 | $37.56M | +258.6% |
| 2020 | $10.47M | +5.0% |
| 2019 | $9.98M | -93.3% |
| 2018 | $148.38M | +2214.1% |
| 2017 | $6.41M | -22.4% |
| 2016 | $8.26M | - |